What Businesses & Engineers Need to Know About Recent Changes in U.S. Patent Law
1 Pre-Appeal Brief Conference (with Demo) By: Bennett Celsa Jean Witz Kathleen Bragdon TC1600 Quality Assurance Specialists.
Patenting Antisense Oligonucleotides and Methods Robert A. Schwartzman, Ph.D. Acting Supervisory Patent Examiner Art Unit 1636.
Determining Obviousness under 35 USC 103 in view of KSR International Co. v. Teleflex TC3600 Business Methods January 2008.
USPTO Guidelines for Determining Obviousness in View of the Supreme Court Decision in KSR International Co. v. Teleflex Inc. TC 1600 Biotech/Chem/Pharma.
Patent Engineering IEOR 190G CET: Center for Entrepreneurship &Technology
